Iteos Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

iTeos Therapeutics

12/05/2022 22:42

* Iteos Therapeutics Inc  ITOS.OQ  reported quarterly
adjusted
earnings of $1.82​​ per share for the quarter ended in March.
The mean expectation of five analysts for the quarter was
for earnings of 80 cents per share.
    * Revenue was $152.52 million​;  analysts expected $63.30
million. 
    * Iteos Therapeutics Inc's reported EPS for the quarter was
$1.82​.
    * The mean earnings estimate of analysts had fallen by
about 26%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Iteos Therapeutics Inc shares had fallen by 44.1% this
quarter and lost 61.3% so far this year.
    * The company reported quarterly net income of $69.58
million.
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $52.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:41 p.m.  ​All
figures in US dollars unless otherwise stated